Determination of premiums in the health insurance sector is a very complicated task. People are living longer and are seeking more health insurance than earlier generations did. Health insurance companies have to balance the effects of new medicines that tackle health problems with fewer side effects, along with the natural risk increases from aging.

There was a time when a diagnosis of cancer was synonymous with death, and for years, a person suffering from HIV/AIDS was considered a hopeless case as far as health insurance was concerned. However, improvements in medical technology and new medicines are helping medical establishments take better care of patients.

Newer solutions and medicines help individuals not only readily overcome serious illnesses but also help them avoid other age-related problems without significant difficulty. In such a scenario, the impact of the new medicines has been very positive in the health insurance sector.

The presence of new medicines is good news for health insurance as it widens the market. A person suffering from high cholesterol used to be considered as a very high-risk candidate for heart attack by health insurance companies. Today, new medicines help individuals bring their cholesterol levels under control without significant side effects.

A person who would be a prime candidate for heart disease can now confidently carry out physical exertion and activities without any fear of health problems. The reduction of health problems has resulted in the reduction of premiums. This, in turn, will make health insurance more affordable for all.

However, the presence of new medicines and better technology in the market is not always a good thing. This is true for the health insurance sector as well. Many new medicines that claim to defeat cancer or negate the effects of AIDS are far too expensive for average individuals.

Secondly, there are numerous risks associated with new technologies and new medicines that health insurance companies have to consider. Even if a cure for cancer were to be discovered tomorrow, it will take many years of testing before the same is made available for the masses. The combination of delays and high costs means that the average individual cannot immediately enjoy the benefits of latest revolutionary medicine coming out of the labs.

The health insurance sector must balance the benefits and risks involved in use of new medicines. They also have to consider how it will affect their market and how they can chose premiums to attract maximum clients without negatively affecting profits. However, the current trend of new and better medicines will continue to make health insurance more affordable.